Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors
Small GTPases · 04.05.2018 · 9 (3) · 203-215
DOI: 10.1080/21541248.2016.1218407 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small GTPases, online erschienen am 22.08.2016. Verfasst von Michael F Olson. Beteiligte Einrichtung: a Cancer Research UK Beatson Institute , Garscube Estate, Glasgow , UK. Hauptthemen laut MEDLINE: Mutation, Protein Processing, Post-Translational. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Cancer Research UK, Medical Research Council, Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
The 20 members of the Rho GTPase family are key regulators of a wide-variety of biological activities. In response to activation, they signal via downstream effector proteins to induce dynamic alterations in the organization of the actomyosin cytoskeleton. In this review, post-translational modifications, mechanisms of dysregulation identified in human pathological conditions, and the ways that Rho GTPases might be targeted for chemotherapy will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- a Cancer Research UK Beatson Institute , Garscube Estate, Glasgow , UK.
Förderung
- Cancer Research UK
- Medical Research Council
- Engineering and Physical Sciences Research Council
Zitieren
APA
Olson, M. F. (2018). Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases, 9(3), 203-215. https://doi.org/10.1080/21541248.2016.1218407
Vancouver
Olson MF. Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases. 2018;9(3):203-215. doi:10.1080/21541248.2016.1218407
BibTeX
@article{Olson2018,
author = {Olson, Michael F},
title = {Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors},
journal = {Small GTPases},
year = {2018},
volume = {9},
number = {3},
pages = {203--215},
doi = {10.1080/21541248.2016.1218407}
}
EUVIMED